TCM
COGT icon

TCG Crossover Management’s Cogent Biosciences COGT Stock Holding History

TCG Crossover Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188M Sell
4,854,436
-92,458
-2% -$3.23M 4.52% 4
2026
Q1 		$190M Sell
4,946,894
-921,268
-16% -$34M 5.45% 4
2025
Q4 		$208M Sell
5,868,162
-930,000
-14% -$26.1M 6.9% 2
2025
Q3 		$97.6M Sell
6,798,162
-166,213
-2% -$1.97M 4.8% 3
2025
Q2 		$50M Hold
6,964,375
– – 5.71% 3
2025
Q1 		$41.7M Hold
6,964,375
– – 5.69% 2
2024
Q4 		$54.3M Hold
6,964,375
– – 5.31% 4
2024
Q3 		$75.2M Hold
6,964,375
– – 6.37% 3
2024
Q2 		$58.7M Buy
6,964,375
+750,000
+12% +$5.69M 6.12% 5
2024
Q1 		$41.8M Buy
6,214,375
+583,333
+10% +$3.61M 3.3% 12
2023
Q4 		$33.1M Hold
5,631,042
– – 3.67% 14
2023
Q3 		$54.9M Hold
5,631,042
– – 8.08% 2
2023
Q2 		$66.7M Buy
5,631,042
+2,000,000
+55% +$22.9M 10.93% 3
2023
Q1 		$39.2M Hold
3,631,042
– – 7.64% 2
2022
Q4 		$42M Buy
3,631,042
+150,000
+4% +$1.86M 7.41% 3
2022
Q3 		$51.9M Hold
3,481,042
– – 15.58% 2
2022
Q2 		$31.4M Buy
3,481,042
+500,000
+17% +$3.41M 13.34% 1
2022
Q1 		$22.3M Buy
2,981,042
+231,005
+8% +$1.61M 8.96% 3
2021
Q4 		$23.6M Buy
+2,750,037
New +$23.9M 11.05% 3

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TCG Crossover Management's COGT Position: Q2 2026 in Review

TCG Crossover Management reduced its Cogent Biosciences (COGT) stake by 1.9% in Q2 2026, selling an estimated $3.23M and leaving 4,854,436 shares worth $188M. The position accounts for 4.52% of the portfolio, ranked #4.

TCG Crossover Management first reported a position in COGT in Q4 2021 and has held it in 19 quarters since. The position peaked at $208M in Q4 2025. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • TCG Crossover Management held 4,854,436 shares of Cogent Biosciences worth $188M as of Q2 2026.
  • TCG Crossover Management sold 92,458 Cogent Biosciences shares in Q2 2026, an estimated $3.23M.
  • Cogent Biosciences made up 4.52% of TCG Crossover Management's portfolio in Q2 2026, its #4 holding.
  • TCG Crossover Management first reported a position in Cogent Biosciences in Q4 2021 and has held it in 19 quarters since.
  • TCG Crossover Management's Cogent Biosciences position peaked at $208M in Q4 2025.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on TCG Crossover Management's 13F filing for Q2 2026, filed 14 Aug 2026.